Wuhan Healthgen Biotechnology Company Description
Wuhan Healthgen Biotechnology Corp. engages in the research and development of molecular pharmaceuticals in China.
The company offers recombinant human serum albumin, proteins for cosmetics ingredients, and other recombinant proteins.
It also provides recombinant growth factors, such as recombinant human epidermal growth factor, recombinant human basic fibroblast growth factor, recombinant human insulin-like growth factor-1 LR3, recombinant human vascular endothelial, recombinant human keratinocyte growth factor, recombinant human fibronectin, recombinant human α-1 antitrypsin, recombinant human lactoferrin, recombinant human epidermal growth factor, and recombinant human fibronectin.
In addition, it provides recombinant protein expression, purification process development, and detection methodology services.
The company was founded in 2006 and is based in Wuhan, China.
| Country | China |
| Founded | 2006 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 278 |
| CEO | Daichang Yang |
Contact Details
Address: 268 Shendun 5th Road Wuhan, 430020 China | |
| Phone | 86 27 5940 3931 |
| Website | oryzogen.com |
Stock Details
| Ticker Symbol | 688765 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100007D17 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Daichang Yang | Chairman and GM |
| Dan Yu | Chief Financial Officer |
| Zhi Jie Qin | Chief Medical Officer |
| Xue Li | Secretary of the Board |
| Bo Shi | Deputy General Manager |
| Liangliang Dong | Senior Director of Scientific Research Projects |
| Jiquan Ou | Director of Scientific Research Projects |
| Nili Wang | Senior Manager of Scientific Research Projects |